AstraZeneca wins fresh U.S. funding in race for COVID-19 treatment

(Reuters) - AstraZeneca (AZN.L) on Tuesday received $23.7 million in funding from a U.S. government agency to advance the development of antibody-based COVID-19 treatments as the British drugmaker ramps up efforts beyond its potential vaccine to combat the pandemic.

from Offbeat » Manila Bulletin News
Read The

Post a comment


Author Name

Contact form


Email *

Message *

Powered by Blogger.